Skip to main content
. 2021 Oct 15;100(41):e27457. doi: 10.1097/MD.0000000000027457

Table 2.

Multivariable regression results using generalized estimating equations (GEE) with Poisson distribution modeling the predictors of cervical cancer screening.

Characteristics Incidence rate ratio (IRR) 95% CI P-value
HPV vaccine status
 None Reference
 Received of ≥1 HPV vaccine 1.34 (1.33–1.35) <.0001
 One dose 1.14 (1.13–1.16) <.0001
 Two doses 1.39 (1.37–1.41) <.0001
 Three doses 1.60 (1.58–1.63) <.0001
P for linear trend <.0001
Age of the patients
 21 Reference
 22 1.13 (1.11–1.14) <.0001
 23 1.20 (1.18–1.21) <.0001
 24 1.29 (1.27–1.30) <.0001
 25 1.32 (1.31–1.34) <.0001
 26 1.41 (1.39–1.43) <.0001
P for linear trend <.0001
Place of residence
 Rural 0.97 (0.96–0.98) <.0001
 Urban reference
US census region
 South Reference
 West 0.79 (0.78–0.80) <.0001
 Midwest 0.96 (0.95–0.97) <.0001
 Northeast 1.05 (1.04–1.06) <.0001
STDs
 Gonorrhea 0.98 (0.84–1.15) .81
 Chlamydia 1.06 (1.03–1.10) .0001
 Syphilis 1.00 (0.72–1.39) .99
 Trichomoniasis 0.97 (0.87–1.08) .61
 HIV/AIDS 0.88 (0.67–1.14) .33
 Hepatitis B virus 1.11 (0.89–1.39) .37
 Hepatitis C virus 0.90 (0.77–1.07) .23
Non-STDs
 Flu vaccination 0.94 (0.92–0.97) .0001
 Previous Pap test 1.22 (1.21–1.24) <.0001
 Alcohol drinking 0.97 (0.89–1.06) .51
 Smoking 0.95 (0.90–0.99) .03
 Drug abuse 0.87 (0.78–0.97) .01
 Depression 1.02 (0.99–1.04) .24
 Anxiety 1.03 (1.00–1.05) .03
 None Reference
Type of health plan
 PPO Reference
 HMO 0.94 (0.93–0.95) <.0001
 CDHP/HDHP 0.93 (0.92–0.94) <.0001
 Others 0.90 (0.89–0.91) <.0001